BioNTech SE Increase Decrease Through Other Changes Liabilities Arising From Financing Activities
BioNTech SE (BNTX) reported Increase Decrease Through Other Changes Liabilities Arising From Financing Activities of -EUR 16.80 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-10.
Financial Statements › Cash Flow › Operating Activities
ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities · last filed 2026-03-10
| Period end | Increase Decrease Through Other Changes Liabilities Arising From Financing Activities 12 month | Increase Decrease Through Other Changes Liabilities Arising From Financing Activities 12 month as first filed |
|---|---|---|
| 2025-12-31 | -16.80M EUR 20-F · filed 2026-03-10 | |
| 2024-12-31 | 5.70M EUR 20-F · filed 2026-03-10 | |
| 2023-12-31 | -3.60M EUR 20-F · filed 2025-03-10 | |
| 2022-12-31 | -406.30M EUR 20-F · filed 2024-03-20 | |
| 2021-12-31 | 17.00M EUR 20-F · filed 2023-03-27 | |
| 2020-12-31 | -1.50M EUR 20-F/A · filed 2022-10-26 | 15.87M EUR 20-F · filed 2021-03-30 |